Sort
30,917 grants matching “tumor microenvironment”
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers
$316,864Richard A. Cerione · Cornell University · R01 · FY2020 · CA
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
$316,861Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Project-2:Defining the role of compartmentalized neuro-lymphatic networks on CRC and metastatic progression
$316,860Daniel S Mucida · Rockefeller University · U54 · FY2022 · CA
Mechanisms of cutaneous immunobiology:Skin immune organ
$316,811Louis D Falo · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · AI
Imaging hypoxia-driven signaling pathways in the breast tumor microenvironment
$316,792Kristine Glunde · Johns Hopkins University · R01 · FY2008 · CA
Potential of a dominant-negative FGF mutant as a therapeutic in cancer
$316,783Yoshikazu Takada · University Of California At Davis · R01 · FY2009 · CA
Manipulation of Tumor Specific Immunity
$316,778Hans Schreiber · University Of Chicago · R01 · FY2024 · CA
Project 1: Hypoxia and metabolic dysregulation as a targetable barrier to immunotherapy in head and neck squamous cell carcinoma (HNSCC)
$316,751Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens
$316,749Shreya Raghavan · Texas Engineering Experiment Station · R37 · FY2023 · CA
Core 1: Biospecimens Core
$316,740Jann N Sarkaria · Massachusetts Institute Of Technology · U54 · FY2024 · CA
Molecular and Cellular Mechanisms of Tumor Development
$316,738Caroline Margaret Alexander · University Of Wisconsin-Madison · T32 · FY2014 · CA
Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment
$316,731Elise C. Kohn · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Project 3: Determining biomarkers for responsiveness to immunotherapy targeting LAG3/PD1 in HNSCC
$316,687Tullia Carmela Bruno · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · CA
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.
$316,635Muller Fabbri · University Of Hawaii At Manoa · R01 · FY2020 · CA
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.
$316,635Muller Fabbri · University Of Hawaii At Manoa · R01 · FY2021 · CA
To Understand/Augment OX40-mediated Tumor Immunotherapy
$316,618Providence Portland Medical Center · R01 · FY2005 · CA
To Understand/Augment OX40-mediated Tumor Immunotherapy
$316,618Providence Portland Medical Center · R01 · FY2004 · CA
To Understand/Augment OX40-mediated Tumor Immunotherapy
$316,618Providence Portland Medical Center · R01 · FY2003 · CA
Carbonic anhydrase and pH control in breast cancer cells
$316,567Susan Cooke Frost · University Of Florida · R01 · FY2014 · CA
An engineered platform for the study of metastasis (PQ #24)
$316,513Peter C Searson · Johns Hopkins University · R01 · FY2012 · CA
Targeting myeloma via dendritic cells
$316,480Madhav V Dhodapkar · Rockefeller University · R01 · FY2007 · CA
Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer
$316,458Deidre B Pereira · University Of Florida · R01 · FY2010 · CA
Host-tumor interactions and cancer relapse after radiation therapy
$316,438Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2018 · CA
Host-tumor interactions and cancer relapse after radiation therapy
$316,438Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2017 · CA
Host-tumor interactions and cancer relapse after radiation therapy
$316,438Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2014 · CA